Contract 75F40123C00196
Virginia Commonwealth University · Department Of Health And Human Services · July 20, 2024
Virginia Commonwealth University was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on July 20, 2024 for $323,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Richmond, VA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 9, 2025. If all options are exercised, the contract could reach $876,000.
Contract details
- PIID
- 75F40123C00196
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Special Studies/Analysis- Chemical/Biological
- Place of performance
- Richmond, VA
- First action
- July 20, 2024
- Latest action
- July 9, 2025
Description
NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 29, 2026.
Modification timeline
-
July 9, 2025Mod P00003 · Other Administrative Action$876.4K
-
July 20, 2024Mod P00002 · Exercise An OptionIN VITRO AND IN VIVO ASSESSMENT OF BUPRENORPHINE EXTENDED RELEASE INJECTIONS FOR GENERIC PRODUCT EQUIVALENCE$876.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40123C00196?
Contract 75F40123C00196 is a federal contract awarded to Virginia Commonwealth University by Department Of Health And Human Services on July 20, 2024 for $323,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75F40123C00196?
Virginia Commonwealth University won contract 75F40123C00196 from Department Of Health And Human Services.
How much is contract 75F40123C00196 worth?
Contract 75F40123C00196 has obligated $323,000 to date, with a total potential value of $876,000 if all options are exercised.